Cytarabine as a salvage mobilization strategy after failure of cyclophosphamide-based stem cell collection for Daratumumab-treated multiple myeloma patients
Tommaso Perini, Alessia Orsini, Francesca Farina, Valeria Ferla et autres
Treatment of multiple myeloma (MM) is rapidly evolving, with new immunotherapies based on bispecific T cell engagers and CAR-T cells changing the therapeutic paradigm. Nonetheless, high-dose melpha...
it (code pays fourni par la source)